OXYMYCINE LA DIN 02259958
Status: Cancelled Post Market
Holder: ZOETIS CANADA INC
Health Canada record
| Active ingredient(s) | OXYTETRACYCLINE (OXYTETRACYCLINE DIHYDRATE) 200 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular; Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 23-Dec-2004 |
| Current status date | 01-Jun-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing OXYTETRACYCLINE (OXYTETRACYCLINE DIHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02248663 | ALAMYCIN 200 LA | NORBROOK LABORATORIES LTD. | Solution | OXYTETRACYCLINE (OXYTETRACYCLINE DIHYDRATE) 200 MG | Marketed |
| 02339935 | ALAMYCIN 300 LA | NORBROOK LABORATORIES LTD. | Solution | OXYTETRACYCLINE (OXYTETRACYCLINE DIHYDRATE) 300 MG | Marketed |
| 02182890 | BIO-MYCIN 200 | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Solution | OXYTETRACYCLINE (OXYTETRACYCLINE DIHYDRATE) 200 MG | Marketed |
| 02157209 | LIQUAMYCIN LA-200 | ZOETIS CANADA INC | Solution | OXYTETRACYCLINE (OXYTETRACYCLINE DIHYDRATE) 200 MG | Marketed |
| 00670804 | ALAMYCIN LA | NORBROOK LABORATORIES LTD. | Solution | OXYTETRACYCLINE (OXYTETRACYCLINE DIHYDRATE) 200 MG | Cancelled Post Market |
| 02248742 | CYCLOSOL 200 LA | EUROVET ANIMAL HEALTH B.V. | Solution | OXYTETRACYCLINE (OXYTETRACYCLINE DIHYDRATE) 200 MG | Dormant |
| 02287080 | NOROMYCIN LA 300 | NORBROOK LABORATORIES LTD. | Solution | OXYTETRACYCLINE (OXYTETRACYCLINE DIHYDRATE) 300 MG | Cancelled Post Market |
| 02237673 | OXY LA | CITADEL ANIMAL HEALTH | Solution | OXYTETRACYCLINE (OXYTETRACYCLINE DIHYDRATE) 200 MG | Cancelled Pre Market |
| 00728357 | OXYMYCINE LA (OXYTETRACYLINE INJECTION) | WYETH ANIMAL HEALTH, DIVISION OF WYETH CANADA | Solution | OXYTETRACYCLINE (OXYTETRACYCLINE DIHYDRATE) 200 MG | Cancelled Post Market |
| 02274892 | OXYMYCINE LA 300 | ZOETIS CANADA INC | Solution | OXYTETRACYCLINE (OXYTETRACYCLINE DIHYDRATE) 300 MG | Cancelled Post Market |
| 02184575 | OXYVET 200 LA | VETOQUINOL N A INC | Solution | OXYTETRACYCLINE (OXYTETRACYCLINE DIHYDRATE) 200 MG | Cancelled Post Market |
| 02184621 | TETRADURE LA 300 STERILE INJECTABLE SOLUTION | NORBROOK LABORATORIES LTD. | Solution | OXYTETRACYCLINE (OXYTETRACYCLINE DIHYDRATE) 300 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 20321 | 2018-01-15 | Supplement to a New Drug Submission (SNDS) | CHANGE TO PRESCRIPTION STATUS. LABELLING UPDATES |
| 15194 | 2014-02-04 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER (DIN) HOLDER |
| 13078 | 2012-03-06 | New Drug Submission (NDS) | Change in DIN owner |
| 5767 | 2004-11-02 | New Drug Submission (NDS) |